Quanterix investor relations material

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's proprietary platform offers high sensitivity to detect various proteins at concentrations as low as one part per trillion. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.